| scholarly article | Q13442814 |
| P2093 | author name string | P Neuhaus | |
| S Jonas | |||
| T Heinze | |||
| A Kärsten | |||
| P433 | issue | 4A | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| P304 | page(s) | 2501-2503 | |
| P577 | publication date | 1999-07-01 | |
| P1433 | published in | Anticancer Research | Q326290 |
| P1476 | title | Determination of the oncogenes p53 and C-erb B2 in the tumour cytosols of advanced hepatocellular carcinoma (HCC) and correlation to survival time | |
| P478 | volume | 19 |
| Q34611637 | A multi-institutional phase II study of the efficacy and tolerability of lapatinib in patients with advanced hepatocellular carcinomas |
| Q35064510 | Alpha-fetoprotein expression is a potential prognostic marker in hepatocellular carcinoma |
| Q28078111 | HER2 aberrations and heterogeneity in cancers of the digestive system: Implications for pathologists and gastroenterologists |
| Q24685729 | Mutation of p53 in recurrent hepatocellular carcinoma and its association with the expression of ZBP-89 |
| Q35588545 | Overexpression/amplification of HER-2/neu is uncommon in hepatocellular carcinoma |
| Q35810123 | Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature |
| Q64279990 | Recognition of HER2 expression in hepatocellular carcinoma and its significance in postoperative tumor recurrence |
| Q39562856 | Selective cytotoxicity of goniothalamin against hepatoblastoma HepG2 cells. |
| Q37269298 | Suppressing activity of tributyrin on hepatocarcinogenesis is associated with inhibiting the p53-CRM1 interaction and changing the cellular compartmentalization of p53 protein. |
| Q42180761 | TOP2A amplification and overexpression in hepatocellular carcinoma tissues. |
| Q34668320 | The prognostic molecular markers in hepatocellular carcinoma |
Search more.